Literature DB >> 8889399

Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users.

R E Booth1, T J Crowley, Y Zhang.   

Abstract

This study was designed to assess the effect of client characteristics and community interventions on treatment entry and retention, and to evaluate the relative effectiveness of treatment, compared to other interventions, in reducing drug use and crime among out-of-treatment opiate injectors. Subjects (N = 2973) from 15 cities were randomly assigned to: standard intervention (SI)-HIV testing and counseling; or enhanced intervention (EI)-SI plus additional educational sessions stressing responsible drug use. EI in some cities included staff assistance with treatment admission (i.e. "active' referral). All locations provided intervention by community outreach workers. Factors positively associated with treatment entry included: prior treatment, intervention by community workers, assignment to the EI, not injecting cocaine, injecting opiates, and fewer program interventions received. Sites where the EI included active referral achieved significantly higher treatment entry rates than sites where the EI did not. Findings supported the efficacy of treatment over other interventions in reducing drug use and arrests, the addition of staff assistance to facilitate clients' entry into treatment, and the involvement of community outreach workers in achieving treatment entry.

Entities:  

Mesh:

Year:  1996        PMID: 8889399     DOI: 10.1016/0376-8716(96)01257-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.

Authors:  G A Zarkin; R C Lindrooth; B Demiralp; W Wechsberg
Journal:  Health Serv Res       Date:  2001-06       Impact factor: 3.402

3.  Why health insurers should pay for addiction treatment. Treatment works and would lead to net societal benefits.

Authors:  D Breithaupt
Journal:  West J Med       Date:  2001-06

4.  Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of intensive role induction.

Authors:  Elizabeth C Katz; Barry S Brown; Robert P Schwartz; Kevin E O'Grady; Stuart D King; Devang Gandhi
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

Review 5.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

Review 6.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  Why don't out-of-treatment individuals enter methadone treatment programmes?

Authors:  James A Peterson; Robert P Schwartz; Shannon Gwin Mitchell; Heather Schacht Reisinger; Sharon M Kelly; Kevin E O'Grady; Barry S Brown; Michael H Agar
Journal:  Int J Drug Policy       Date:  2008-09-20

8.  Multiplex Relationships and HIV: Implications for Network-Based Interventions.

Authors:  Abby E Rudolph; Natalie D Crawford; Carl Latkin; Crystal Fuller Lewis
Journal:  AIDS Behav       Date:  2017-04

Review 9.  Outreach-based HIV prevention for injecting drug users: a review of published outcome data.

Authors:  S L Coyle; R H Needle; J Normand
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 10.  Drug abuse treatment as AIDS prevention.

Authors:  D S Metzger; H Navaline; G E Woody
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.